These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7940725)

  • 81. Immunotherapy with autologous bone-marrow transplantation: rationale and results.
    Bilgrami S; Silva M; Cardoso A; Miller KB; Ascensao JL
    Exp Hematol; 1994 Oct; 22(11):1039-50. PubMed ID: 7523161
    [No Abstract]   [Full Text] [Related]  

  • 82. [Occurrence and therapy of conjunctival changes in graft versus host reaction following bone marrow transplantation].
    Giovannini A; Amatetti S; Carloni S
    Fortschr Ophthalmol; 1986; 83(1):70-1. PubMed ID: 3519397
    [No Abstract]   [Full Text] [Related]  

  • 83. Third party mediated graft rejection despite irradiation of blood products.
    Sproul AM; Chalmers EA; Mills KI; Burnett AK; Simpson E
    Br J Haematol; 1992 Feb; 80(2):251-2. PubMed ID: 1550784
    [No Abstract]   [Full Text] [Related]  

  • 84. Weight loss, skin rash, and cough following bone marrow transplantation for chronic myelogenous leukemia.
    Witherspoon RP; McGlave P; Campbell JB; Sigley T; Rolston KV
    Cancer Pract; 1998; 6(4):202-5. PubMed ID: 9767331
    [No Abstract]   [Full Text] [Related]  

  • 85. Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease.
    Qasim W; Derniame S; Gilmour K; Chiesa R; Weber M; Adams S; Rao K; Amrolia P; Goulden N; Veys P; Gaspar H
    Br J Haematol; 2011 Jul; 154(1):150-3. PubMed ID: 21501134
    [No Abstract]   [Full Text] [Related]  

  • 86. [Allogeneic cord blood hematopoietic stem cell transplantation in two cases of children with leukemia].
    Tang YM; Song H; Yang SL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 36(6):626-8. PubMed ID: 18067240
    [No Abstract]   [Full Text] [Related]  

  • 87. Facial premature ageing as a side-effect following bone marrow transplantation.
    Selvaag E; Jacobsen N; Thomsen K
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):566-8. PubMed ID: 12941096
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Penetrating keratoplasty in severe ocular graft versus host disease.
    Heath JD; Acheson JF; Schulenburg WE
    Br J Ophthalmol; 1993 Aug; 77(8):525-6. PubMed ID: 8025052
    [No Abstract]   [Full Text] [Related]  

  • 89. One center's experience with implementing extracorporeal photopheresis in a pediatric setting.
    Tomlin K; Clarke S; Cojocari E
    Transfus Apher Sci; 2015 Dec; 53(3):423-6. PubMed ID: 26653929
    [No Abstract]   [Full Text] [Related]  

  • 90. Graft-versus-host disease. Case report and discussion.
    Eggleston TI; Ziccardi VB; Lumerman H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Dec; 86(6):692-6. PubMed ID: 9868727
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Coping with major illness.
    Hanna SK
    J Oral Maxillofac Surg; 1999 Mar; 57(3):356. PubMed ID: 10077213
    [No Abstract]   [Full Text] [Related]  

  • 92. Amplification of the graft-versus-leukemia effect in man by interleukin-2.
    Verdonck LF; van Heugten HG; Giltay J; Franks CR
    Transplantation; 1991 May; 51(5):1120-4. PubMed ID: 2031266
    [No Abstract]   [Full Text] [Related]  

  • 93. Blaschkoid Acute Graft-vs-Host Disease.
    Gupta V; Arava S; Ramam M
    JAMA Dermatol; 2018 Apr; 154(4):494-495. PubMed ID: 29387872
    [No Abstract]   [Full Text] [Related]  

  • 94. Graft-versus-leukemia after second allogeneic bone marrow transplantation.
    Aoki Y; Takahashi S; Okamoto S; Asano S
    Blood; 1994 Dec; 84(11):3983. PubMed ID: 7949156
    [No Abstract]   [Full Text] [Related]  

  • 95. Pentostatin for the treatment of chronic graft-versus-host disease in children.
    Goldberg JD; Jacobsohn DA; Margolis J; Chen AR; Anders V; Phelps M; Vogelsang GB
    J Pediatr Hematol Oncol; 2003 Jul; 25(7):584-8. PubMed ID: 12847332
    [TBL] [Abstract][Full Text] [Related]  

  • 96. My Patient, the Superhero.
    Muffly L
    J Clin Oncol; 2017 Apr; 35(12):1368-1369. PubMed ID: 28165900
    [No Abstract]   [Full Text] [Related]  

  • 97. 2-Chlorodeoxyadenosine as treatment of severe acute graft-versus-host disease.
    Pless M; Gratwohl A; Tichelli A; Speck B; Betticher DC
    Blood; 1994 Aug; 84(3):987-9. PubMed ID: 7913846
    [No Abstract]   [Full Text] [Related]  

  • 98. Transient elevation of serum rheumatoid factor following bone marrow transplantation.
    Manabe S; Kodo H; Kumakawa T; Asano S; Mori S; Miwa S
    Transplant Proc; 1987 Apr; 19(2):2971-4. PubMed ID: 3551243
    [No Abstract]   [Full Text] [Related]  

  • 99. Graft-versus-host disease: the face of the aggressor.
    Van Noesel CJ; De Wit M; Hollak CE
    Br J Haematol; 2002 Sep; 118(4):932. PubMed ID: 12199769
    [No Abstract]   [Full Text] [Related]  

  • 100. Involvement of macrophages in lethal forms of graft-versus-host disease.
    Facon T; Janin A; Noel MP; Jouet JP
    Lancet; 1995 Feb; 345(8946):392. PubMed ID: 7845145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.